Fig. 6From: Proposal for a definition of "Oligometastatic disease in pancreatic cancer"Patients fulfilling criteria for oligometastatic disease, as shown in Table 1, show a significantly longer median overall survival compared to the remaining patients (19.4 vs 7.2 months; 95% CI 5.7–9.8; p = 0.009)Back to article page